Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Jabbour Jerome D, Chief Executive Officer. Insider active across 1 company, notably Matinas BioPharma Holdings, Inc.. Aggregated, 2 filings have been published. History available since 19 June 2021. The latest transaction was filed on 19 June 2021 (J). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Jerome D. Jabbour is the President and Chief Executive Officer at Matinas BioPharma Holdings, Inc. He is responsible for the strategic and operational leadership of the company. His experience in the pharmaceutical sector is essential in supporting the company's growth and innovation.